Henry Schein Inc. (NASDAQ:HSIC) – Analysts at William Blair decreased their Q3 2016 earnings per share estimates for Henry Schein in a research report issued on Monday. William Blair analyst J. Kreger now expects that the brokerage will post earnings of $1.65 per share for the quarter, down from their previous forecast of $1.66. William Blair also issued estimates for Henry Schein’s FY2016 earnings at $6.56 EPS and FY2018 earnings at $7.97 EPS.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. Henry Schein’s quarterly revenue was up 9.3% on a year-over-year basis. During the same quarter last year, the company earned $1.46 EPS.
A number of other brokerages have also issued reports on HSIC. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, July 5th. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target on the stock in a report on Tuesday. Robert W. Baird reissued an “outperform” rating and issued a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a report on Tuesday, October 4th. Finally, Bank of America Corp. began coverage on shares of Henry Schein in a report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $160.50.
Henry Schein (NASDAQ:HSIC) opened at 156.05 on Wednesday. The firm’s 50-day moving average is $162.38 and its 200 day moving average is $170.17. The firm has a market cap of $12.76 billion, a PE ratio of 26.44 and a beta of 1.05. Henry Schein has a 1-year low of $142.64 and a 1-year high of $183.00.
In other news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the sale, the director now directly owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.27% of the company’s stock.
Several hedge funds have recently made changes to their positions in HSIC. Quadrant Capital Group LLC raised its stake in shares of Henry Schein by 0.4% in the second quarter. Quadrant Capital Group LLC now owns 742 shares of the company’s stock worth $128,000 after buying an additional 3 shares during the last quarter. Montag & Caldwell LLC raised its stake in shares of Henry Schein by 0.3% in the second quarter. Montag & Caldwell LLC now owns 2,700 shares of the company’s stock worth $477,000 after buying an additional 7 shares during the last quarter. Cleararc Capital Inc. raised its stake in shares of Henry Schein by 0.9% in the second quarter. Cleararc Capital Inc. now owns 2,013 shares of the company’s stock worth $356,000 after buying an additional 17 shares during the last quarter. Wetherby Asset Management Inc. raised its stake in shares of Henry Schein by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 3,350 shares of the company’s stock worth $592,000 after buying an additional 20 shares during the last quarter. Finally, Ranger Investment Management L.P. raised its stake in shares of Henry Schein by 1.5% in the second quarter. Ranger Investment Management L.P. now owns 1,370 shares of the company’s stock worth $242,000 after buying an additional 20 shares during the last quarter. 91.98% of the stock is currently owned by hedge funds and other institutional investors.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.